PriceTargets.com logo

Solventum - SOLV Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $87.00
  • Forecasted Upside: 2.05%
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 8 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$85.25 As of 12/4/2025 04:59 PM ET
▼ -0.001 (0.00%)

This chart shows the closing price for SOLV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Solventum Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SOLV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SOLV

Analyst Price Target is $87.00
▲ +2.05% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Solventum in the last 3 months. The average price target is $87.00, with a high forecast of $103.00 and a low forecast of $71.00. The average price target represents a 2.05% upside from the last price of $85.25.

This chart shows the closing price for SOLV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 13 investment analysts is to hold stock in Solventum. This rating has held steady since September 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/2/2025BTIG ResearchUpgradeNeutral ➝ Buy$100.00
12/2/2025BTIG ResearchUpgradeNeutral ➝ Buy$100.00
12/1/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
11/21/2025UBS GroupReiterated RatingNeutral ➝ Neutral
11/10/2025UBS GroupBoost TargetNeutral ➝ Neutral$77.00 ➝ $79.00
11/7/2025Piper SandlerBoost TargetOverweight ➝ Overweight$94.00 ➝ $98.00
10/30/2025Weiss RatingsReiterated RatingHold (C) ➝ Hold (C)
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
10/1/2025UBS GroupInitiated CoverageNeutral$77.00
10/1/2025UBS GroupInitiated CoverageNeutral$77.00
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/15/2025Zacks ResearchUpgradeHold ➝ Strong-Buy
9/15/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$79.00 ➝ $82.00
9/11/2025Jefferies Financial GroupInitiated CoverageHold$80.00
8/8/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$75.00 ➝ $79.00
8/8/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$87.00 ➝ $94.00
7/15/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$80.00 ➝ $103.00
7/1/2025ArgusUpgradeHold ➝ Buy$90.00
6/6/2025KeyCorpInitiated CoverageSector Weight
5/19/2025Piper SandlerUpgradeNeutral ➝ Overweight$78.00 ➝ $87.00
5/9/2025Piper SandlerLower TargetNeutral ➝ Neutral$80.00 ➝ $78.00
4/30/2025Piper SandlerLower TargetNeutral ➝ Neutral$84.00 ➝ $80.00
3/5/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$73.00 ➝ $80.00
3/3/2025MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $82.00
3/3/2025The Goldman Sachs GroupBoost TargetSell ➝ Sell$63.00 ➝ $71.00
2/28/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$73.00 ➝ $75.00
2/28/2025Piper SandlerBoost TargetNeutral ➝ Neutral$75.00 ➝ $84.00
2/26/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$80.00 ➝ $85.00
12/4/2024MizuhoInitiated CoverageNeutral$70.00
11/11/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$60.00 ➝ $73.00
11/8/2024Piper SandlerBoost TargetNeutral ➝ Neutral$71.00 ➝ $75.00
10/8/2024Stifel NicolausInitiated CoverageBuy$82.00
10/7/2024Piper SandlerInitiated CoverageNeutral$71.00
9/26/2024Wolfe ResearchInitiated CoveragePeer Perform
9/5/2024BTIG ResearchInitiated CoverageNeutral
8/12/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$48.00 ➝ $54.00
8/9/2024Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$69.00 ➝ $64.00
7/15/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$70.00 ➝ $55.00
7/10/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$54.00 ➝ $48.00
6/25/2024Bank of AmericaLower TargetNeutral ➝ Neutral$70.00 ➝ $60.00
6/24/2024ArgusInitiated CoverageHold
5/30/2024The Goldman Sachs GroupInitiated CoverageSell$54.00
5/10/2024Bank of AmericaInitiated CoverageNeutral$70.00
4/10/2024Morgan StanleyInitiated CoverageEqual Weight$70.00
4/8/2024Wells Fargo & CompanyInitiated CoverageEqual Weight$69.00
4/2/2024Edward JonesInitiated CoverageHold
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.04 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 51 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 24 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 29 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 49 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 29 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 28 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 58 very positive mentions
  • 41 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 58 very positive mentions
  • 41 positive mentions
  • 1 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Solventum logo
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
Read More

Today's Range

Now: $85.25
Low: $84.66
High: $85.64

50 Day Range

MA: $74.82
Low: $66.25
High: $85.79

52 Week Range

Now: $85.25
Low: $60.70
High: $88.20

Volume

929,667 shs

Average Volume

1,183,639 shs

Market Capitalization

$14.79 billion

P/E Ratio

9.82

Dividend Yield

N/A

Beta

0.26

Frequently Asked Questions

What sell-side analysts currently cover shares of Solventum?

The following Wall Street research analysts have issued research reports on Solventum in the last twelve months: Argus, Bank of America Corporation, BTIG Research, Jefferies Financial Group Inc., KeyCorp, Mizuho, Morgan Stanley, Piper Sandler, The Goldman Sachs Group, Inc., UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for SOLV.

What is the current price target for Solventum?

0 Wall Street analysts have set twelve-month price targets for Solventum in the last year. Their average twelve-month price target is $87.00, suggesting a possible upside of 2.1%. Morgan Stanley has the highest price target set, predicting SOLV will reach $103.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $71.00 for Solventum in the next year.
View the latest price targets for SOLV.

What is the current consensus analyst rating for Solventum?

Solventum currently has 1 sell rating, 8 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SOLV, but not buy more shares or sell existing shares.
View the latest ratings for SOLV.

What other companies compete with Solventum?

Other companies that are similar to Solventum include GE HealthCare Technologies, Koninklijke Philips, Zimmer Biomet, Smith & Nephew SNATS and Penumbra. Learn More about companies similar to Solventum.

How do I contact Solventum's investor relations team?

The company's listed phone number is 651-733-1110 and its investor relations email address is [email protected]. The official website for Solventum is www.solventum.com. Learn More about contacing Solventum investor relations.